Literature DB >> 294092

The cause of striae distensae.

S Shuster.   

Abstract

Striae are always initiated by stretch whether the stretch is excessive or minimal: spontaneous striae do not occur. Cross-linkage of collagen appears to be more important than amount of collagen in permitting striae in response to stretch. An increase in cross linkage as in age increases the resistance to stretch deformation, but this rigidity leads ultimately to tearing of the skin and not striae. At the other extreme, the absence of crosslinkage leads to "elasticity" and excessive stretching with eventual rupture of the skin if the stretch goes beyond the elastic limit, but again, no striae. Striae appear to occur therefore only in skin in which the rigid cross-linked collagen and "elastic" unlinked collagen thus permitting a limited degree of stretch and a limited intradermal rupture, i.e. striae. (Although rigidity and elasticity are presented here in terms of collagen cross-linkage it seems probable that changes in interfibrillary materials such as glycosaminoglycans will prove important in this respect). This balance of stretch and limited tear is a continuous process and is an adaptation to the needs of growth in adolescence and change in body mass in early adult life and there are many many subclinical "striae" for each gross tear which is recognised clinically. An important factor likewise appears to be rate of stretch since if it is very slow, striae are less likely; there is "give" and new collagen formation. Although this working hypothesis is consonant with the facts only further work will show whether this smooth consonance is that of the fable or the weathered rock of fact.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 294092

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  11 in total

1.  Risk factors for the development of striae gravidarum.

Authors:  Hibah Osman; Nelly Rubeiz; Hala Tamim; Anwar H Nassar
Journal:  Am J Obstet Gynecol       Date:  2007-01       Impact factor: 8.661

2.  Evaluation of Various Therapeutic Measures in Striae Rubra.

Authors:  Umesh Karsandas Karia; Bela Bhemabhai Padhiar; Bela Jaswantbhai Shah
Journal:  J Cutan Aesthet Surg       Date:  2016 Apr-Jun

3.  A qualitative study of the factors influencing recruitment to a pilot trial on the prevention of striae gravidarum.

Authors:  Miriam Brennan; Mike Clarke; Declan Devane; Maura Dowling
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-12       Impact factor: 3.007

4.  Treating Striae Distensae Albae in Asians: Efficacy and Safety of Combined MFU-V and CaHA.

Authors:  Joyce Teng Ee Lim
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-02-25

Review 5.  Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.

Authors:  Sean Yilong Tan; Nisha Suyien Chandran; Ellie Ci-En Choi
Journal:  Clin Drug Investig       Date:  2021-08-18       Impact factor: 2.859

6.  Perception of Stretch Marks Risk Factors Among Adults in Riyadh, Saudi Arabia.

Authors:  Renad A Alageel; Abrar E Bukhari; Amani S Alotaibi; Reeman S Alsalman; Malak M Aldakhilallah; Jihan J Siddiqui; Ibrahim A Al-Omair; Eman A Almukhadeb
Journal:  Cureus       Date:  2021-11-14

7.  Imaging striae distensae: a comparison between PS-OCT and digital dermoscopy.

Authors:  Wai Ching Lin; Robert A Byers; Wei Li; Simon G Danby; Michael J Cork; Stephen J Matcher
Journal:  Biomed Opt Express       Date:  2021-05-11       Impact factor: 3.732

8.  Topical steroid-damaged skin.

Authors:  Anil Abraham; Gillian Roga
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

9.  The use of anti stretch marks' products by women in pregnancy: a descriptive, cross-sectional survey.

Authors:  Miriam Brennan; Mike Clarke; Declan Devane
Journal:  BMC Pregnancy Childbirth       Date:  2016-09-21       Impact factor: 3.007

Review 10.  Striae gravidarum: Risk factors, prevention, and management.

Authors:  B Farahnik; K Park; G Kroumpouzos; J Murase
Journal:  Int J Womens Dermatol       Date:  2016-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.